Close Menu

This story has been updated from a previous version to include a statement from a University of California spokesperson.

NEW YORK – In the fight between the Broad Institute and the University of California, Berkeley for the bulk of the intellectual property rights to CRISPR-Cas9 technology, the United States Patent and Trademark Office's Patent Trial and Appeal Board (PTAB) issued a new ruling this week that may have given the Broad the definitive upper hand.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

AstraZeneca has released its coronavirus vaccine trial protocol, according to the New York Times.

Time magazine looks into how liquid biopsies are changing cancer care.

According to the Guardian, more than 150 countries have signed on to a global SARS-CoV-2 vaccine plan.

In PNAS this week: similar muscle protein patterns across hypertrophic cardiomyopathy phenotypes, analysis of gene expression and brain anatomy in major depression, and more.